Christopher Paige, Director at AVROBIO, Inc. (AVRO), sold 10,000 shares at $25.59 ($257K) on 2019-04-05, disclosed to the SEC on 2019-04-09.
Scheduled sale ($257k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.59 | 6,633 | $170K | 66.0% |
| 2 | $26.21 | 867 | $23K | 8.8% |
| 3 | $25.84 | 2,400 | $62K | 24.1% |
| 4 | $26.92 | 100 | $3K | 1.0% |
| Total | $25.72 avg | 10,000 | $257K | 100% |
| Filing → |